MetaCap

Advanced Biomed (ADVB) vs iSpecimen (ISPC)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Advanced Biomed is the larger company by market cap ($10.1 million vs $2.7 million), about 3.7 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ADVB-1.45%ISPC-0.91%
+0%-1%-2%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ADVB versus ISPC key metrics
MetricADVBISPC
Share price$6.12$1.09
Market cap$10.11M$2.75M
1-day change-2.86%-0.91%
YTD return+4.79%—
1-year return-34.89%—
P/E ratio (TTM)1.26—
EPS (TTM)$4.85$-52.98
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$24.23$37.60
52-week low$3.61$1.02
Distance from 52-week high-74.74%-97.10%
Average volume1.75M667.50K
Shares outstanding1.65M2.52M
Employees317
SectorHealth CareHealth Care
IndustryMedical SpecialitiesBiotechnology: Commercial Physical & Biological Resarch

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Advanced Biomed is about 3.7 times larger than iSpecimen by market value ($10.11M vs $2.75M).

About Advanced Biomed

ADVB stock →

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product.

Health Care · Medical Specialities · 31 employees

About iSpecimen

ISPC stock →

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Health Care · Biotechnology: Commercial Physical & Biological Resarch · 7 employees

ADVB vs ISPC FAQ

Which is bigger, Advanced Biomed or iSpecimen?

Advanced Biomed (ADVB) is larger, with a market capitalization of $10.11M compared with $2.75M for iSpecimen (ISPC).

Are Advanced Biomed and iSpecimen in the same industry?

Both are in the Health Care sector, but in different industries: Medical Specialities for Advanced Biomed and Biotechnology: Commercial Physical & Biological Resarch for iSpecimen.

More comparisons